Genetic Origin of Lipid Disorders

NCT00277121 · Status: UNKNOWN · Type: OBSERVATIONAL

Last updated 2006-01-13

No results posted yet for this study

Summary

Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. The resulting mutations will be tested in suitable in vitro systems to detect their part in development of the specific disease.

Conditions

  • Lipid Disorder

Sponsors & Collaborators

  • Lipid Clinic, The National Hospital, Oslo, Norway

    collaborator UNKNOWN
  • Research Institute of Internal Medicine, The National Hospital, Oslo, Norway

    collaborator UNKNOWN
  • Ullevaal University Hospital

    collaborator OTHER
  • Norwegian Institute of Public Health

    collaborator OTHER_GOV
  • Hormone Laboratory, Aker University Hospital, Oslo, Norway

    collaborator OTHER
  • CIGENE, Agricultural University of Norway, Aas, Norway

    collaborator OTHER
  • University of Oslo

    lead OTHER

Principal Investigators

  • Hilde I Nebb, PhD · Department of Nutrition, University of Oslo

  • Karianne Solaas, PhD · Department of Nutrition, University of Oslo

  • Monica H Carlsen · Department of Nutrition, University of Oslo

  • Leiv Ose, Dr med · Lipid Clinic, The National Hospital

  • Marit S Nenseter, PhD · Research Institute of Internal Medicine, The National Hospital

  • Kirsten Holven, PhD · Research Institute of Internal Medicine, The National Hospital

  • Bente Halvorsen, PhD · Research Institute of Internal Medicine, The National Hospital

  • Serena Tonstad, Dr med · Department of Preventive Medicine, Ullevål university hospital

  • Håkon Gjessing, PhD · Norwegian Institute of Public Health

  • Per Thorsby, Dr med · Hormone laboratory, Aker university hospital

  • Sigbjørn Lien, PhD · Agricultural university of Norway

  • Paul Berg, PhD · Agricultural university of Norway

  • Kjetil Retterstøl, Dr med · Lipid Clinic, The National Hospital

Eligibility

Min Age
18 Years
Max Age
54 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00277121 on ClinicalTrials.gov